Compare ZJYL & POM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ZJYL | POM |
|---|---|---|
| Founded | 2006 | 2015 |
| Country | China | China |
| Employees | N/A | N/A |
| Industry | Industrial Specialties | Other Specialty Stores |
| Sector | Consumer Discretionary | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 32.7M | 38.8M |
| IPO Year | 2023 | 2025 |
| Metric | ZJYL | POM |
|---|---|---|
| Price | $0.16 | $0.24 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 1.3M | 489.8K |
| Earning Date | 08-20-2025 | 12-03-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | $22,826,624.00 | ★ $51,210,721.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | $13.19 | ★ N/A |
| Revenue Growth | ★ 13.42 | 12.13 |
| 52 Week Low | $0.11 | $0.25 |
| 52 Week High | $1.03 | $6.43 |
| Indicator | ZJYL | POM |
|---|---|---|
| Relative Strength Index (RSI) | 39.35 | 24.58 |
| Support Level | $0.12 | $0.28 |
| Resistance Level | $0.18 | $0.32 |
| Average True Range (ATR) | 0.03 | 0.03 |
| MACD | -0.00 | 0.12 |
| Stochastic Oscillator | 30.12 | 9.83 |
Jin Medical International Ltd offers rehabilitation equipment. It is engaged in the design, development, manufacturing, and sales of wheelchairs and other living aids products to be used by people with disabilities or impaired mobility. The company's products are sold to distributors in both China and overseas markets. Its product offerings comprise Wheelechaire serirs, Bath products, oxygen machines, and nursing products. Geographically, it generates the majority of its revenue from Japan.
Pomdoctor Ltd is an online medical services platform for chronic diseases in China. With a focus on chronic disease management and pharmaceutical services, its business model forms a one-stop platform for medical services, which organically connects patients to doctors and pharmaceutical products. Its experience in tackling chronic diseases can be traced back to the launch of its platform on mobile devices. The company operates in two segments: Internet hospital, and Pharmaceutical supply chain. The majority of revenue is derived from the Pharmaceutical supply chain segment.